Learn More
Cayman Chemical Troglitazone, 97322-87-7, 5 mg

Supplier: Cayman Chemical 717505

Molecular Formula C24H27NO5S, Purity ≥98%, Formula Weight 441.5, Synonyms: Resulin™; Troglitazone is a TZD which was approved for the treatment of insulin resistance and hyperglycemia in Type II diabetes, under the trade name Resulin™, but was withdrawn from the market due to hepatotoxicity. Troglitazone is a potent and selective PPAR agonist. The EC50 values for transactivation of human and mouse PPAR in a cell-based assay are 0.55 and 0.78 M, respectively.{10670} In the same assay system, no activation of PPAR and PPAR.delta. was observed at concentrations up to 10 M. Troglitazone binds to the PPAR ligand-binding domain (LBD) but fails to induce interaction of the PPAR LBD with the transcriptional coactivators SRC-1, TIF2, AIB1, p300, or TRAP220.{8555} Troglitazone also induces cell cycle arrest and apoptosis in several cancer cell lines with an EC50 of 10 M.{10669}
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.